TOGA Podcast

Dec 01 2024 45 ep. 26 mins 24
TOGA Podcast artwork

Join TOGA to learn more about lung cancer. Podcasts with leading experts. Patient Interviews. Trial updates.

  Health & Fitness
RSS feed Share
Copy RSS


Subscribe on Podcast Addict


Hit It With Your Best Shot- The Case for IO in Early-Stage NSCLC in a Once in a Lifetime World

Dec 01 2024 27 mins  
Our latest podcast explores the case for IO in early-stage NSCLC in our once in a lifetime world – the current Australian context. We review the medical oncology and surgical perspective of the current evidence for clinical benefit and what we have available in Australia. As clinicians, we are trained to give our best treatment up front, so patient discussion is important in an e

Large-Cell Neuroendocrine Carcinoma of the Lung (LCNEC): Challenges in Diagnosis and Treatment

Nov 14 2024 23 mins  
In this episode, we discuss the clinical and diagnostic markers when identifying a rare sub type of NSCLC, large-cell neuroendocrine carcinomas (LC-NEC), and provide insights into the management of these patients and future treatment developments. Associate Professor Rachel Wong, Deputy Director Oncology Eastern Health and Medical Oncologist at Epworth East in Melbourne is joined

Management of Limited-Stage Small Cell Lung Cancer (LS-SCLC)

Sep 30 2024 18 mins  
In this episode, we dive into the latest survival data from the ADRIATIC trial, as presented at ASCO 2024, which could change the treatment landscape for LS-SCLC. Joining us are leading experts in oncology Zarnie Lwin, Susan Harden and Wei-Sen Lam. Together, they explore the significance of the ADRIATIC trial results, debate the role of prophylactic cranial irradiation (PCI) in the

NTRK1, 2,3 And Other Rare Mutations In NSCLC

Aug 29 2024 21 mins  
In this TOGA podcast, we provide an overview of the treatment options for rare subtypes of oncogene driven NSCLC that are now readily identified in the MBS-reimbursed small gene panel including NTRK1, 2,3 and other rare mutations in NSCLC. The importance of testing all patients is discussed as well as what to do when resistance occurs. Associate Professor Steven Kao, Medical Onco

Decoding Perioperative Immunotherapy In NSCLC

Jul 24 2024 21 mins  
In this TOGA podcast, we provide an overview of the recent neoadjuvant, adjuvant, and perioperative IO data, the options and considerations for treatment and the current reimbursement landscape. Dr Pei Ni Ding, Medical Oncologist from Westmead and Nepean Hospitals Sydney, is joined by Dr Samantha Bowyer, Medical Oncologist from Sir Charles Gairdner Hospital in Perth and Mr Naveed A

Access to New Medicines: Which Surrogate Endpoints Matter

Jun 19 2024 24 mins  
Do we need to evolve the bar on evidence required for drug reimbursement? The gold standard endpoint for assessing the benefit of anti-cancer drugs has been overall survival (OS) however, more recently, there has been a trend toward using surrogate clinical trial endpoints such as progression free survival (PFS) and event-free survival (EFS). As treatments improve and patients are

Lung Cancer Nurses: Essential, Beneficial and a Key Link In Lung Cancer Screening

Apr 21 2024 35 mins  
People living with lung cancer experience a high level of unmet needs, high levels of psychological stress, and a poor quality of life. Additionally, they tend to underutilise hospital and community support services. This situation makes access to a lung cancer nurse imperative. A dedicated nurse can provide essential support and care, improving the well-being of patients with lung

Underutilisation of Radiotherapy in Lung Cancer Treatment

Mar 26 2024 24 mins  
Radiation therapy can be a very effective treatment for lung cancers, with 77% of patients indicating for radiation therapy in their disease trajectory. Yet, only 40% of patients with lung cancer in NSW receive radiation therapy. In this podcast, Professor Shalini Vinod, Assoc Professor Mei-Ling Yap, and Dr Clare Bajraszewski discuss why radiation therapy is underutilised in lung

Revolutionising Lung Cancer Healthcare with AI: Unlocking the Future

Feb 28 2024 30 mins  
Artificial intelligence (AI) is transforming medicine. Lung Cancer healthcare professionals are interested in the use of AI in radiology, particularly in early diagnosis leading to better patient outcomes. In this podcast we will explore how AI can aid in early detection, accurate interpretation of imaging scans and reduce diagnostic errors. This episode is joined by Associate Prof

Antibody Drug Conjugates (ADCs) – An Emerging Treatment Platform in Lung Cancer

Dec 14 2023 29 mins  
In this TOGA Podcast the speakers discuss Antibody Drug Conjugates (ADCs) – An Emerging Treatment Platform in Lung Cancer. The discussion explores the different molecules and mechanisms of drugs currently available, trial results and the subsequent place of ADCs in the Lung Cancer. Furthermore, our guests expand upon the management of patients receiving these drugs. A/Prof Meli